Skip to main content
OpenTrials

Clinical trial condition

Bone Marrow Diseases

Explore clinical trials studying Bone Marrow Diseases. Study availability and eligibility vary by location and protocol.

3,005 public trials 529 recruiting studies
Refine in advanced search Browse all conditions

Bone Marrow Diseases trial results

Recruiting

A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)

NCT06782373

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hematologic Neoplasms, +7 more
Locations
  • Mayo Clinic - Scottsdale Scottsdale, Arizona, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic - Rochester Rochester, Minnesota, United States
  • NYU Langone Health New York, United States
View all 39 locations
View Trial Details
Recruiting

Open-label Study of Asciminib for CML-CP or CML-AP Patients With T315I Mutation Who Are Resistant, Intolerant or Ineligible to Ponatinib.

NCT06514534

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia (CML), +11 more
Locations
  • Novartis Investigative Site Bordeaux, France
  • Novartis Investigative Site Lille, France
  • Novartis Investigative Site Lyon, France
  • Novartis Investigative Site Nantes, France
View Trial Details
Recruiting

A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy

NCT06247787

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
View all 19 locations
View Trial Details
Recruiting

Asciminib RMP Study

NCT05943522

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Novartis Investigative Site Wŏnju, Gangwon-do, South Korea
  • Novartis Investigative Site Anyang-si, Gyeonggi-do, South Korea
  • Novartis Investigative Site Bucheon-si, Gyeonggi-do, South Korea
  • Novartis Investigative Site Uijeongbu-si, Gyeonggi-do, South Korea
View all 17 locations
View Trial Details
Recruiting

Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis

NCT06517875

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • GSK Investigational Site Ann Arbor, Michigan, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Nashville, Tennessee, United States
  • GSK Investigational Site Houston, Texas, United States
View all 33 locations
View Trial Details

Related conditions